Sign Up to like & get
recommendations!
2
Published in 2023 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022008854
Abstract: Key Points • TIM-3 is the only immune-checkpoint receptor consistently overexpressed in patients with CML who relapse after TKI cessation.• Overexpression of TIM-3 provides a rationale to test TIM-3 inhibitors to modify treatment-free remission outcomes.
read more here.
Keywords:
tim;
checkpoint receptor;
treatment free;
free remission ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Oncology Letters"
DOI: 10.3892/ol.2019.10428
Abstract: A characteristic feature of testicular seminoma is the abundance of immune cells in the tumor microenvironment, raising the possibility that immune checkpoint inhibitors may serve as a therapeutic option in these types of tumors. T…
read more here.
Keywords:
immune checkpoint;
tigit;
checkpoint receptor;
checkpoint ... See more keywords